Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle

Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

Proteomic and phospholipidomic characterization of extracellular vesicles inducing tumor microenvironment in Epstein‐Barr virus‐associated lymphomas

Increase in constitutively active MEK1 species by introduction of MEK1 mutations identified in cancers